Transcenta Holding-B (02617.HK) received a filing notice from the China Securities Regulatory Commission regarding the implementation of the full circulation of the Company's H shares.

Zhitong Finance APP News, TransThera-B (02617.HK) announced that on October 26, 2026, the Company received a filing notice (the Filing Notice) issued by the China Securities Regulatory Commission (CSRC) regarding the implementation of the Company's full circulation of H shares. According to the Filing Notice, the Company has completed the filing with the CSRC for the implementation of the conversion of 44,971,128 domestic shares of the Company held by such shareholders into H shares of the Company (H Shares). The Filing Notice is valid for 12 months from the date of issuance of the Filing Notice. The Company will apply to the Listing Committee of the Stock Exchange for approval of the listing and trading of the relevant H Shares.